MATTHEW DINCHER: Open Payments
NPI 1992083992 · BECKLEY, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,225 in 157 payments from 11 companies in 2025. Trend: 2023 $1,211 · 2024 $1,148 · 2025 $2,225
Food & beverage: $2,135Education: $90
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 53 | $628 |
| Janssen Biotech, Inc. | 49 | $581 |
| UCB, Inc. | 19 | $377 |
| Lilly USA, LLC | 8 | $186 |
| Galderma Laboratories, L.P. | 16 | $182 |
| Regeneron Healthcare Solutions, Inc. | 4 | $119 |
| Incyte Corporation | 2 | $53 |
| Arcutis Biotherapeutics, Inc. | 3 | $47 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
Products named: TREMFYA, SKYRIZI, Bimzelx, TALTZ, NEMLUVIO, RINVOQ, DUPIXENT, OPZELURA.
Industry payments across WV — which companies pay providers there.
